Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06463678

Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis

A Phase II, Multi-center, Randomized, Masked, Parallel-Control Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% PVP-Iodine) Gel Forming Ophthalmic Solution in the Treatment of Fungal Keratitis

Sponsor: IVIEW Therapeutics Inc.

Conditions Fungal Keratitis

Interventions IVIEW-1201 NATACYN®

Updated 4 times since 2024 Last updated: Oct 12, 2025 Started: Aug 1, 2026 Primary completion: Dec 31, 2027 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Fungal Keratitis, this trial is actively recruiting participants. The trial is conducted by IVIEW Therapeutics Inc. and has accumulated 4 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Nov 2025 — Present [monthly]

Not Yet Recruiting PHASE2
Sep 2025 — Nov 2025 [monthly]

Not Yet Recruiting PHASE2
Sep 2024 — Sep 2025 [monthly]

Not Yet Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

IVIEW Therapeutics Inc.

Data source: IVIEW Therapeutics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.